Intas Pharmaceuticals Ltd
Leuprolide (11.25mg)
Leupo 11.25mg Injection is used to treat prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.
Injection
Leupo 11.25mg Injection is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids and central precocious puberty (very early puberty).
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Reduces the amount of sex hormones (testosterone in men and estrogen in women)..Decreases the blood levels of testosterone in males..Shuts off hormones made by the ovaries (female reproductive organs) so the estrogen level is lowered.
Use non-hormonal methods of contraception such as condoms to prevent pregnancy during treatment as this medicine may be harmful to a developing baby. Long term treatment may lead to bone loss and a higher risk of bone fractures especially if you are a heavy drinker, a smoker, or have a family history of osteoporosis.
No, Leupo 11.25mg Injection is not a chemotherapy medicine. It is a synthetic hormone analogue medicine used for the treatment of hormone-dependent conditions in men and women.
Yes, Leupo 11.25mg Injection may lead to cessation of periods as this medicine alters reproductive hormones. Sometimes vaginal bleeding may occur. Please contact your doctor if you experience such bleeding and follow their guidance.
Yes, Leupo 11.25mg Injection is a hormonal medicine that alters reproductive hormones in females. This medication is not recommended for use during pregnancy as it may harm the fetus in the womb. Using this medicine during pregnancy may also lead to abortion. Please inform your doctor if you are pregnant or planning to become pregnant before starting this treatment.
Yes, there is a possibility of Leupo 11.25mg Injection affecting your bones. This medicine may decrease bone mineral density and weaken the bones. In women, bone density should be assessed before starting treatment. Special care and monitoring are necessary in women with increased risk of osteoporosis. If needed, additional medicines may be prescribed to prevent the development of osteoporosis.
Yes, Leupo 11.25mg Injection can potentially increase blood sugar levels, leading to poor glucose control for individuals with diabetes. It may even raise the risk of developing diabetes. Regular monitoring of blood glucose and glycosylated hemoglobin (HbA1c) is necessary, along with informing your doctor if you experience any problems.